منابع مشابه
[Guideline for diagnosis and treatment for COPD].
COPDは増加傾向にあり,WHOの予測によると 2020 年には世界の死因の第 3位になると考えられている (1990 年においてはCOPDは死因の第 6位).当科の福 地らが中心となり報告した疫学調査(NICE study)に よると本邦におけるCOPD患者数は,530 万人,40 歳 以上の 8.6%と報告されており,本邦においてもCOPD による死亡症例は増加すると考えられており,今後の早 期診断,早期治療介入は呼吸器内科医にとって重要な課 題である.世界的には,COPDのガイドライン(global Initiative for Chronic Obstructive Lung Disease(GOLD)) が定期的に発刊されており,今年の暮れに新しいガイド ライン(GOLD2012)の概要が明らかになる予定である. 本邦においては日本呼吸器学会が 1999 年以来 COPDの...
متن کاملACP updates guideline on diagnosis and management of stable COPD.
www.aafp.org/afp Volume 85, Number 2 ◆ January 15, 2012 Chronic obstructive pulmonary disease (COPD) affects more than 5 percent of U.S adults and is the third leading cause of death. Manifestations of COPD range from dyspnea and poor exercise tolerance to chronic cough, wheezing, and respiratory failure. In cooperation with the American College of Chest Physicians, American Thoracic Society, a...
متن کاملDo family physicians' records fit guideline diagnosed COPD?
BACKGROUND In family practice, chronic obstructive pulmonary disease (COPD) is usually not diagnosed until clinically apparent and of moderately advanced severity. OBJECTIVE To analyse the diagnostic process from early development onwards and to assess the current state of underpresentation and underdiagnosis of COPD and asthma in primary care in the Netherlands. METHODS The population-base...
متن کاملComparison of Korean COPD Guideline and GOLD Initiative Report in Term of Acute Exacerbation: A Validation Study for Korean COPD Guideline
The purpose of this study was to compare the Korean COPD guideline to GOLD consensus report in terms of acute exacerbation. A total of 361 patients were enrolled in this study, and 16.9% of them experienced acute exacerbation during the follow-up. A total of 6.3% of patients in GOLD A, 9.5% in GOLD B, 7.7% in GOLD C and 17.0% of GOLD D experienced exacerbation during the first year of follow-up...
متن کاملChronic obstructive pulmonary disease v 12: New treatments for COPD
There is a major need to develop new treatments for chronic obstructive pulmonary disease (COPD), as no currently available drug therapy reduces the relentless progression of the disease. In particular, there is a need to develop drugs that control the underlying inflammatory and destructive processes. There have been few therapeutic advances in the drug treatment of COPD, in contrast to the en...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Naika Gakkai Zasshi
سال: 2012
ISSN: 0021-5384,1883-2083
DOI: 10.2169/naika.101.1631